Zibo Qixiang Tengda Chemical Co., Ltd
002408.SZ · SHZ
Analyst ratings
hold · 0 ratings
| Date | Firm | Action | Rating | Price target |
|---|
Sustainability of the recent profitability surge
The company reported a staggering 374–424% year-over-year increase in net profit for H1 2026, driven by chemical cycle recovery, rising product prices, and accelerating overseas capacity rationalization. These structural tailwinds, combined with over 50% growth in overseas trading revenue, suggest the earnings rebound has durable foundations.
Despite the impressive H1 2026 profit jump, the company recorded negative results for three consecutive prior quarters and a multi-year decline in net sales and operating profit. The profitability surge appears heavily tied to volatile international energy prices and cyclical factors, raising doubts about its longevity.
Stock valuation and long-term return potential
A DCF valuation estimates the intrinsic value of Zibo Qixiang Tengda's stock at CNY 5.30, compared to a current market price of CNY 4.74, suggesting the stock is undervalued by approximately 11%. This discount may represent an attractive entry point for investors anticipating a continued earnings recovery.
The company's return on equity remains persistently low, and despite being net-debt free, it has struggled to convert its balance sheet strength into shareholder value. The stock's recent intraday gains mask a five-year track record of declining fundamentals, calling into question the reliability of DCF-based upside estimates.
Market growth opportunity in maleic anhydride and specialty chemicals
The global maleic anhydride market is projected to grow from USD 1.84 billion in 2025 to USD 3.79 billion by 2035 at a CAGR of 7.62%, with Zibo Qixiang Tengda identified as a key participant. New high-value projects — including a high-performance catalytic new materials project and aldehyde-series specialty chemicals — are already generating returns and diversifying the product portfolio.
While the maleic anhydride market outlook is broadly positive, the competitive landscape includes numerous global and regional players. Domestic overcapacity risks in China's chemical sector, combined with trade tensions and environmental regulatory pressures, could compress margins and limit Zibo Qixiang Tengda's ability to fully capture projected market growth.